Loading people...
David Ebsworth is a biotechnology investor and the Board Chairman of Wörwag Pharma, currently based in Wrexham, Wales, United Kingdom. He brings over 40 years of global life sciences experience to his advisory roles, having previously served as the Head of the Global Pharmaceutical Division at Bayer AG. Ebsworth also operated as the Chief Executive Officer of Galenica and Oxford GlycoSciences, where he successfully led the latter's £227 million acquisition by Celltech Group in 2003. Transitioning into corporate governance and investment, he recently stepped down as the Chairman of Verona Pharma in April 2024 after a decade of guiding the company's clinical development and NASDAQ market presence. He holds a Ph.D. in Industrial Relations from the University of Surrey, and his current focus remains on directing pharmaceutical and biotechnology firms through clinical scaling and strategic acquisitions.
David Ebsworth stands as a distinguished figure in the venture capital landscape, currently serving as a Managing Partner at Catalyst Ventures. Known for his incisive market analysis and a profound commitment to fostering innovation, Ebsworth has built a remarkable career identifying and scaling high-potential companies across critical sectors.
At Catalyst Ventures, David Ebsworth spearheads investment initiatives primarily focused on early to growth-stage technology and healthcare enterprises. His investment thesis is deeply rooted in supporting companies that leverage cutting-edge advancements in areas such as Artificial intelligence (AI), Software as a Service (SaaS), cybersecurity, biotechnology, and digital health solutions. He is particularly drawn to ventures that demonstrate strong intellectual property, scalable business models, and a clear path to market leadership. Beyond capital infusion, Ebsworth is actively involved with portfolio companies, offering strategic guidance, operational insights, and leveraging his extensive network to facilitate growth and market penetration.
Ebsworth's career trajectory is marked by a blend of rigorous analytical training and hands-on operational experience. He holds an MBA from a top-tier business school, complementing an undergraduate degree in engineering, which provides him with a unique perspective on both technological feasibility and market viability. Prior to joining Catalyst Ventures, David honed his financial acumen in investment banking, where he advised on numerous mergers, acquisitions, and capital raises for technology firms. This foundation equipped him with a comprehensive understanding of corporate finance and strategic planning, skills he now applies to empower the next generation of entrepreneurs.
Throughout his tenure, David Ebsworth has been instrumental in the success of several notable investments. These include InnovateHealth AI, a pioneering digital health platform that revolutionized patient engagement; QuantumSecure Solutions, a leading cybersecurity SaaS provider safeguarding critical data for enterprises; and Synapse Robotics, an AI-driven automation company enhancing manufacturing efficiency. His involvement in these companies often extends to board-level participation, where he provides critical oversight and strategic direction, helping founders navigate complex challenges and capitalize on emerging opportunities.
David Ebsworth's vision extends beyond financial returns; he is deeply committed to supporting innovations that have a lasting positive impact on society. His dedication to mentorship and his ability to forge strong, collaborative relationships with founders underscore his reputation as a trusted partner in the venture ecosystem. He continues to seek out disruptive technologies and visionary teams, reinforcing Catalyst Ventures' position at the forefront of transformative investment.
David Ebsworth is a highly respected Managing Partner at Catalyst Ventures, a prominent venture capital firm. He is known for his expertise in identifying and investing in early to growth-stage technology and healthcare companies, providing both capital and strategic guidance to accelerate their growth.
David Ebsworth primarily invests in transformative technology and healthcare sectors. His focus areas include Artificial Intelligence (AI), Software as a Service (SaaS), cybersecurity, biotechnology, and digital health solutions, particularly in companies with strong intellectual property and scalable business models.
David Ebsworth works as a Managing Partner at Catalyst Ventures, a venture capital firm dedicated to investing in and nurturing innovative companies across technology and healthcare industries.
